CBCT Guided Markerless SBRT for Renal Cell Cancer

This study aims to improve the treatment of kidney tumors using radiotherapy, by investigating whether kidney cancer can be more effectively irradiated with the help of new imaging techniques

Trial Details

NCT ID
NCT07402109
Phase
NA
Sponsor
Erasmus Medical Center
Status
RECRUITING
Cancer Type
Kidney Cancer
Interventions
  • Additional radiation due to imaging
Locations (sample)
  • Rotterdam, South Holland, Netherlands|51.9225,4.47917

Key Eligibility Criteria

  • Patients with histologically proven non-metastastic RCC or high suspicion of RCC based on imaging without histological evidence
  • No metastatic lesions
  • Patients must be 18 years or older
  • Ability to understand the requirements of the study and to give written informed consent, as determined by the treating physician.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Kidney Cancer Trials on Trialify →